Eric Hoffman on a Very Discreet Newcomer: Synthetic Biology
By Eric Hoffman,
A World of Science
| 01. 11. 2013
Synthetic biology was one of the themes discussed at the Assises du vivant, a forum organized jointly by UNESCO and the French NGO Vivagora in Paris on 30 November. Synthetic biology is still in its infancy but it has great ambitions: to create entirely new life forms. Borrowing techniques from engineering, the synthetic biologist assembles different parts (genes) to build an entirely new circuit. At the Assises du vivant, one proponent suggested that synthetic bacteria could be designed to glow whenever they detected explosives in the soil, alerting to buried anti-personnel mines. Others cited the potential for synthetic biofuels, biodegradable plastics and cancer drugs. But some participants were more circumspect. ‘Have the necessary safeguards been put in place? ‘, they asked. ‘Could existing organisms not fulfill the same role? Do we know how existing species will interact with these new life forms of our own creation? And what guarantee is there that they will function in the way we intended? We put these questions to Eric Hoffman, a science and technology policy expert with the US branch of the NGO...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...